EX-FILING FEES 4 tm2221337d1_ex-filingfee.htm EX-FILING FEES

Exhibit 107

 

Calculation of Filing Fee Tables

 

FORM S-3

 

APPLIED DNA SCIENCES, INC.

 

Table 1: Newly Registered and Carry Forward Securities

 

    Security
Type		   Security
Class
Title		   Fee
Calculation
or Carry
Forward
Rule		   Amount
Registered(1)		    

Proposed
Maximum
Offering
Price Per
Unit(2)

     Maximum
Aggregate
Offering
Price(2)		     Fee Rate     Amount of
Registration
Fee		     Carry
Forward
Form
Type		     Carry
Forward
File
Number		    

Carry
Forward
Initial
effective
date

     Filing Fee
Previously
Paid In
Connection
with Unsold
Securities
to be
Carried
Forward		  
Newly Registered Securities
Fees to Be Paid   Equity   Common Stock, par value $0.001 per share(3)   Rule 457(c)     1,496,400 (2)   $ 0.84     $ 1,256,976       0.0000927     $ 116.52                                  
Fees Previously Paid                                                                                    
Carry Forward Securities
Carry Forward Securities                                                                                    
    Total Offering Amounts             $ 1,256,976             $ 116.52                                  
    Total Fees Previously Paid                                                                  
    Total Fee Offsets                                                                  
    Net Fee Due                                                                  

 

(1) Pursuant to Rule 416 under the Securities Act of 1933 (the “Securities Act”), the securities being registered hereunder also include such indeterminate number of additional shares of common stock as may from time to time be issued after the date hereof as a result of stock splits, stock dividends, recapitalizations or similar transactions.

 

(2) Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) of the Securities Act, based on the average of the high and low prices of the common stock of the registrant as reported on The Nasdaq Capital Market on July 18, 2022.

 

(3) Represents shares of our common stock offered by Armistice Capital Master Fund Ltd. (the “Selling Stockholder”) issuable upon the exercise of warrants to purchase common stock issued to the Selling Stockholder in a private placement.